Differential expression of human spasmolytic polypeptide (trefoil factor family-2) in pancreatic carcinomas, ampullary carcinomas, and mucin-producing tumors of the pancreas

Digestive Diseases and Sciences

Volumn 45, Issue 4, 2000, Pages 659-664

  Ohshio, Gakuji ^a,b,c   Suwa, Hirofumi ^a,b,c   Kawaguchi, Yoshiya ^a,b,c   Imamura, Masayuki ^a,b,c   Yamaoka, Yoshio ^a,b,c   Yamabe, Hirohiko ^a,b,c   Matsumoto, Masao ^a,b,c   Yoshioka, Hideyuki ^a,b,c   Hashimoto, Yosuke ^a,b,c   Takeda, Hiroshi ^a,b,c  

^a Shiga Medical Center   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c Dept of Second Div of Int Med   (Japan)

Author keywords

Ampullary carcinoma; Human spasmolytic polypeptide; Mucin producing tumor; Pancreatic carcinoma; Trefoil peptide

Indexed keywords

HUMAN SPASMOLYTIC POLYPEPTIDE; MUCIN; TREFOIL PEPTIDE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOMA; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN SECRETION; VATER PAPILLA CARCINOMA;

ADENOMA, ISLET CELL; AMPULLA OF VATER; ANTIBODIES, MONOCLONAL; CARCINOMA; COMMON BILE DUCT NEOPLASMS; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOMA, MUCINOUS; CYSTADENOMA, SEROUS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MUCINS; MUSCLE PROTEINS; NEOPLASM STAGING; NEUROPEPTIDES; PANCREAS; PANCREATIC NEOPLASMS; PEPTIDES;

EID: 0034074999     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005471005289     Document Type: Article

References (29)

1. 1. Thim L: Trefoil peptides: a new family of gastrointestinal molecules. Digestion 55:353-360, 1994
2. 2. Wright NA, Hoffmann W, Otto WR, Rio MC, Thim L: Rolling in the clover: Trefoil factor family (TFF) -domain peptides, cell migration and cancer. FEBS Lett 408:121-123, 1997
3. 3. Jørgensen KH, Thim L, Jacobsen HE: Pancreatic spasmolytic polypeptide (PSP): 1. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 3:207-219, 1982
4. 4. Jørgensen KD, Diamant B, Jørgensen H, Thim L: Pancreatic spasomlytic polypeptide (PSP): III. Pharmacology of a new porcine pancreatic polypeptide with spasmolytic and gastric acid secretion inhibitory effects. Regul Pept 3:231-243, 1982
5. 5. Tomasetto C, Rio M, Gautier C, Wolf C, Hareuveni M, Chambon P, Lathe R: hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 9:407-414, 1990
6. 6. Hanby AM, Poulsom R, Singh S, Elia G, Jeffery RE, Wright NA: Spasmolytic polypeptide is a major antral peptide: Distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 105:1110-1116, 1993
7. 7. Podolsky DK, Devaney KL, Stow JL, Oates P, Murgue B, Debeaumont M, Sands BE, Mahida YR: Identification of human trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268:6694-6702, 1993
8. 8. Elia G, Chinery R, Hanby AM, Poulsom R, Wright NA: The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochemical J 26:644-647, 1994
9. 9. Dignass A, Lynch-Devaney K, Kindon H, Thim L, Podolsky D: Trefoil peptides promote epitherial migration through a transforming growth factor β-independent pathway. J Clin Invest 94:376-383, 1994
10. 10. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, Thim L, Hanby AM: Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108:108-116, 1995
11. 11. Babyatsky MW, DeBeaumont M, Thim L, Podolsky DK: Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats. Gastroenterology 110:489-497, 1996
12. 12. Poulsom R, Wright N: Trefoil peptides: A new recognized family of epithelial mucin-associated molecules. Am J Physiol 265:G205-G213, 1993
13. 13. Kindon H, Pothoulakis C, Thim L, Lynch-Devaney K, Podolsky DK: Trefoil peptide protection of intestinal epithelial barrier function: Cooperative interaction with mucin glycoprotein. Gastroenterology 109:516-523, 1995
14. 14. Tanaka S, Podolsky DK, Engel E, Guth PH, Kaunitz JD: Human spasmolytic polypeptide decreases proton permeation through gastric mucus in vivo and in vitro. Am J Physiol 272:G1473-G1480, 1997
15. 15. Masiakowski P, Breathnach R, Bioch J, Gannon F, Krust A, Chambon P: Cloning of cDNA sequences of hormone-related genes from the MCF-7 cancer cell line. Nucleic Acid Res 10:7895-7903, 1982
16. 16. Hoosein NM, Thim L, Jorgensen KH, Brattain MG: Growth stimulation effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumour cells. FEBS Lett 247:303-306, 1989
17. 17. Luqmani Y, Bennett C, Paterson I, Corbishley CM, Rio MC, Chambon P: Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int J Cancer 44:806-812, 1989
18. 18. Henry JA, Bennett MK, Piggott NH, Levett DL, May FE, Westley BR: Expression of the pNR-3/pS2 protein in diverse human epitherial tumours. Br J Cancer 64:677-682, 1991
19. 19. Theisinger B, Welter C, Seitz G, Rio MC, Lathe R, Chambon P, Blin N: Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer 27:770-773, 1991
20. 20. Luqmani YA, Ryall G, Shousha S, Coombes RC: An immunohistochemical survey of pS2 expression in human epitherial cancers. Int J Cancer 50:302-304, 1992
21. 21. Welter C, Theisinger B, Seitz G, Tomasetto C, Rio M, Chambon P, Blin N: Association of the human spasmolytic polypeptide and an estrogen-induced breast cancer protein (pS2) with human pancreatic carcinoma. Lab Invest 66:187-192, 1992
22. 22. Kloppel G, Iingenthal G, Vonbulow M, Kern HF: Histological and fine structural features of pancreatic ductal adenocarcinomas in relation to growth and prognosis: Studies in xenografted tumours and clinico-histopathological correlation in a series of 75 cases. Histopathology 9:841-856, 1985
23. 23. Itai Y, Ohhashi K, Nagai H, Murakami Y, Kokubo T, Makita K, Ohtomo K: "Ductectatic" mucinous cystadenoma and cystadenocarcinoma of the pancreas. Radiology 161:697-700, 1986
24. 24. Rickaert F, Cremer M, Deviere J, Tavares L, Lambilliotte JP, Schröder S, Wurbs D, Klöppel G: Intraductal mucin-hypersecreting neoplasms of the pancreas: A clinicopathological study of eight patients. Gastroenterology 101:512-519, 1991
25. 25. Yanagisawa A, Ohashi K, Hori M, Takagi K, Kitagawa K, Sugano H, Kato Y: Ductectatic-type mucinous cystadenoma and cystadenocarcinoma of the human pancreas: A novel clinicopathological entity. Jpn J Cancer Res 84:474-479, 1993
26. 26. Yamaguchi K, Ogawa Y, Chijiwa K, Tanaka M: Mucin-hypersecreting tumors of the pancreas: Assessing the grade of malignancy preoperatively. Am J Surg 171:427-431, 1996
27. 27. Ohshio G, Yoshioka H, Manabe T, Sakahara H, Yamabe H, Imamura M, Inoue M, Tanaka N, Nakada H, Yamashina I: Expression of sialosyl-Tn antigen (monoclonal antibody MLS102 reactive) in normal tissues and malignant tumors of the digestive tract. J Cancer Res Clin Oncol 29:325-330, 1994
28. 28. Wright NA, Poulsom R, Stamp GWH, Hall PA, Jeffery RE, Longcroft JM, Rio MC, Tomasetto C, Chambon P: Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 162:279-284, 1990
29. 29. Eright NA, Poulsom R, Stamp G, Noorden SV, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C, Rio MC, Chambon P: Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104:12-20, 1993